Jay Cross
Director Financiero/CFO en SONNET BIOTHERAPEUTICS HOLDINGS, INC. .
Fortuna: 1 913 $ al 30/04/2024
Perfil
John Harry Cross is currently the Chief Financial & Business Officer at Sonnet BioTherapeutics, Inc. and Sonnet BioTherapeutics Holdings, Inc. He previously worked as the Managing Director-Healthcare Investment Banking at Chardan Capital Markets LLC and as a Director at Alere Financial Partners.
He received his undergraduate degree from Washington & Lee University and his graduate degree from Yale School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/12/2023 | 1 087 ( 0.04% ) | 1 913 $ | 30/04/2024 |
Cargos activos de Jay Cross
| Empresas | Cargo | Inicio |
|---|---|---|
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Director Financiero/CFO | 01/05/2019 |
Sonnet BioTherapeutics, Inc.
 Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Director Financiero/CFO | 01/05/2019 |
Antiguos cargos conocidos de Jay Cross.
| Empresas | Cargo | Fin |
|---|---|---|
Chardan Capital Markets LLC
 Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Corporate Officer/Principal | 01/03/2019 |
Alere Financial Partners
 Alere Financial Partners Investment ManagersFinance Alere Financial Partners provides investment research. The private company is based in King of Prussia, PA. | Director/Miembro de la Junta | 01/06/2015 |
Formación de Jay Cross.
| Washington & Lee University | Undergraduate Degree |
| Yale School of Medicine | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Chardan Capital Markets LLC
Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Finance |
Alere Financial Partners
Alere Financial Partners Investment ManagersFinance Alere Financial Partners provides investment research. The private company is based in King of Prussia, PA. | Finance |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Jay Cross
